(Q51033796)

27 March 2018

title

Anti-HLA antibodies in heart transplantation. (English)

1 reference

27 March 2018

1 reference

8

Donna Mancini

1 reference

27 March 2018

author name string

Elena R Vasilescu

1

1 reference

27 March 2018

Eric K Ho

2

1 reference

27 March 2018

Ludwika de la Torre

3

1 reference

27 March 2018

Silviu Itescu

4

1 reference

27 March 2018

Charles Marboe

5

1 reference

27 March 2018

Raffaello Cortesini

6

1 reference

27 March 2018

Nicole Suciu-Foca

7

1 reference

27 March 2018

publication date

1 January 2004

1 reference

27 March 2018

published in

Transplant Immunology

1 reference

27 March 2018

volume

12

1 reference

27 March 2018

issue

2

1 reference

27 March 2018

page(s)

177-183

1 reference

27 March 2018

Soluble HLA antigens, anti-HLA antibodies, and antiidiotypic antibodies in the circulation of renal transplant recipients

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2003.08.002

Immunomodulation of kidney and heart transplants by anti-idiotypic antibodies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2003.08.002

An immunological algorithm to predict risk of high-grade rejection in cardiac transplant recipients.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2003.08.002

Preformed IgG antibodies against major histocompatibility complex class II antigens are major risk factors for high-grade cellular rejection in recipients of heart transplantation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2003.08.002

Specificity of lymphocytotoxic antibodies formed after cardiac transplantation and correlation with rejection episodes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2003.08.002

The effect of panel reactive antibodies and the donor specific crossmatch on graft survival after heart and heart-lung transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2003.08.002

Soluble MHC class I antigens (sHLA) and anti-HLA antibodies in heart and kidney allograft recipients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2003.08.002

Vascular rejection post heart transplantation is associated with positive flow cytometric cross-matching

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2003.08.002

The role of flow cytometry-detected IgG and IgM anti-donor antibodies in cardiac allograft recipients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2003.08.002

Flow cytometric detection of HLA-specific antibodies as a predictor of heart allograft rejection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2003.08.002

Allograft coronary artery disease: clinical correlations with circulating anti-HLA antibodies and the immunohistopathologic pattern of vascular rejection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2003.08.002

Humoral rejection in cardiac transplantation: risk factors, hemodynamic consequences and relationship to transplant coronary artery disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2003.08.002

Vascular rejection in cardiac transplantation: Histologic, immunopathologic, and ultrastructural features

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2003.08.002

Vascular rejection in cardiac transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2003.08.002

Left ventricular mass increases during cardiac allograft vascular rejection.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2003.08.002

Accelerated coronary vascular disease in the heart transplant patient: coronary arteriographic findings

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2003.08.002

Humoral theory of transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2003.08.002

Indirect recognition of donor HLA-DR peptides in organ allograft rejection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2003.08.002

Mechanism of liver allograft rejection: the indirect recognition pathway

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2003.08.002

Persistent allopeptide reactivity and epitope spreading in chronic rejection of organ allografts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2003.08.002

Specific suppression of T helper alloreactivity by allo-MHC class I-restricted CD8+CD28- T cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2003.08.002

Tolerization of dendritic cells by T(S) cells: the crucial role of inhibitory receptors ILT3 and ILT4

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2003.08.002

Ligation of HLA class I molecules on smooth muscle cells with anti-HLA antibodies induces tyrosine phosphorylation, fibroblast growth factor receptor expression and cell proliferation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2003.08.002

Ligation of HLA class I molecules on endothelial cells induces phosphorylation of Src, paxillin, and focal adhesion kinase in an actin-dependent manner

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2003.08.002

10.1016/J.TRIM.2003.08.002

7 January 2021

Identifiers

DOI

1 reference

27 March 2018

PubMed ID

14967316

1 reference

27 March 2018